Company News
Baird Rates Abbott Outperform, Sets $121 Target
Baird initiates coverage of Abbott Laboratories with an Outperform rating and a $121 price target.
The broker projects 6%‑8% annual revenue growth and low‑double‑digit earnings growth through 2027, dr
